EUVIMEDEUVIMED entdecken
Open Access

STK11 coordinates IL-4 signaling with metabolic reprogramming to control M2 macrophage polarization and antitumor immunity

Jing Yang iD, Naresh Singh iD, Chengxian Xu iD, Dehui Kong iD, Samantha Sharma iD, Sheng Liu, Joseph Lechner, Ankhbayar Lkhagva, Haiyan Tan iD, Zhiping Wu, Martin J Richer iD, Yong Zang iD und 8 weitere

Science Advances · 2025

DOI: 10.1126/sciadv.adx5495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Jing Yang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Herman B Wells Center for Pediatric Research and Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Hauptthemen laut MEDLINE: Interleukin-4, Signal Transduction, Macrophages, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrophages integrate microenvironmental cues to orchestrate complex transcriptional and metabolic programs that drive functional polarization. Here, we demonstrate that STK11 links interleukin-4 (IL-4) signaling with metabolic reprogramming to restrain alternatively activated (M2) macrophage polarization. Through integrative transcriptomic and metabolomic analyses, we identified STK11 as a key transcriptional and metabolic regulator during M2 polarization. STK11 deficiency enhanced the expression of M2-associated markers and promoted glutamine metabolism in IL-4–stimulated macrophages. Mechanistically, STK11 deficiency led to increased FOXO1 activation, thereby promoting M2 polarization. Pharmacological inhibition of FOXO1 or glutamine metabolism effectively reversed the enhanced M2 polarization. In an orthotopic model of pancreatic ductal adenocarcinoma, myeloid-specific deletion of STK11 resulted in increased accumulation of M2-like tumor-associated macrophages, impaired antitumor immunity, and accelerated tumor progression. These findings uncover a previously unrecognized role for STK11 in modulating M2 macrophage polarization, offering mechanistic insights that may inform the development of immunometabolic therapies for pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-4Signal TransductionMacrophagesProtein Serine-Threonine KinasesPancreatic NeoplasmsMacrophage ActivationAnimalsMiceHumansAMP-Activated Protein Kinase KinasesCarcinoma, Pancreatic DuctalTumor-Associated MacrophagesGlutamineCell PolarityCell Line, TumorMice, KnockoutAMP-Activated Protein KinasesMetabolic Reprogramming

Substanzen

Interleukin-4Stk11 protein, mouseProtein Serine-Threonine KinasesAMP-Activated Protein Kinase KinasesSTK11 protein, humanGlutamineAMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Herman B Wells Center for Pediatric Research and Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
  • Indiana University School of Medicine, Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN 46202, USA.
  • Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

ORCID-Profile: Jing Yang, Naresh Singh, Chengxian Xu, Dehui Kong, Samantha Sharma, Haiyan Tan, Martin J Richer, Yong Zang, Xiumei Huang, Jun Wan, Anthony A High, Xinna Zhang, Xusheng Wang, Xiongbin Lu, Kai Yang

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Yang, J., Singh, N., Xu, C., Kong, D., Sharma, S., Liu, S., Lechner, J., Lkhagva, A., Tan, H., Wu, Z., Richer, M. J., Zang, Y., Huang, X., Kapur, R., Wan, J., High, A. A., Zhang, X., Wang, X., Lu, X., & Yang, K. (2025). STK11 coordinates IL-4 signaling with metabolic reprogramming to control M2 macrophage polarization and antitumor immunity. Science Advances. https://doi.org/10.1126/sciadv.adx5495

Vancouver

Yang J, Singh N, Xu C, Kong D, Sharma S, Liu S, et al. STK11 coordinates IL-4 signaling with metabolic reprogramming to control M2 macrophage polarization and antitumor immunity. Science Advances. 2025. doi:10.1126/sciadv.adx5495

BibTeX
@article{Yang2025,
  author = {Yang, Jing and Singh, Naresh and Xu, Chengxian and Kong, Dehui and Sharma, Samantha and Liu, Sheng and Lechner, Joseph and Lkhagva, Ankhbayar and Tan, Haiyan and Wu, Zhiping and Richer, Martin J and Zang, Yong and Huang, Xiumei and Kapur, Reuben and Wan, Jun and High, Anthony A and Zhang, Xinna and Wang, Xusheng and Lu, Xiongbin and Yang, Kai},
  title = {STK11 coordinates IL-4 signaling with metabolic reprogramming to control M2 macrophage polarization and antitumor immunity},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adx5495}
}
Kostenlos starten →